Analyst Research

Report Title Price
Provider: Stock Traders Daily
$20.00
Provider: Pechala's Reports
$15.00
Provider: Stock Traders Daily
$20.00
Provider: Reuters Investment Profile
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Cambrex Corp gives FY 2014 guidance; revenue and EBITDA below analysts' estimates - Conference Call


Tuesday, 11 Feb 2014 08:30am EST 

Cambrex Corp:Says the company expect consolidated FY 2014 sales to increase between 8 pct and 12 pct, excluding the impact of currency and EBITDA to be between $70 million and $76 million.Says the company expected adjusted income continuing operations for FY 2014 to be between $0.99 and $1.10 per share.Reported revenue of $318.18 million in FY 2013.FY 2014 revenue of $341.10 million, EBITDA of $78 million and EPS of $1.09 - Thomson Reuters I/B/E/S. 

Company Quote

21.46
-0.22 -1.01%
22 Aug 2014